CICC: Raise the target price of WuXi AppTec (02359.HK) to 126 Hong Kong dollars, second-quarter performance exceeds expectations

According to the WiseMoney app, Zhongjin released a research report stating that due to the recent increase in the average valuation of the pharmaceutical industry, it maintains an outperform rating on WuXi AppTec (02359.HK) and raises its H-share target price by 59.9% to 126 Hong Kong dollars. Considering the strong demand for core business and improved operating efficiency, it has raised its 2025 and 2026 net profit forecasts by 8.9% and 9.2% respectively to 12.5 billion and 14.4 billion RMB.